Not Cleared Direct

DEN220015 - Orthobond Mariner Pedicle Screw System (FDA 510(k) Clearance)

Apr 2024
Decision
767d
Days
Class 2
Risk

DEN220015 is an FDA 510(k) submission for the Orthobond Mariner Pedicle Screw System. This device is classified as a Spinal Fusion System With 12-methacryloyloxydodecyl Pyridinium Bromide (c21h34brno2) Coating (Class II - Special Controls, product code QZY).

Submitted by Orthobond Coporation (Monmouth, US). The FDA issued a Not Cleared (DENG) decision on April 5, 2024.

This device falls under the Orthopedic FDA review panel. Regulated under 21 CFR 888.3071. A Spinal Fusion System With 12-methacryloyloxydodecyl Pyridinium Bromide (c21h34brno2) Coating Is A Rigid Metallic Implant System Compromised Of Single Or Multiple Components Intended To Provide Immobilization And Stabilization Of Spinal Segments As An Adjunct To Fusion In Skeletally Mature Patients. The Device Includes A 12-methacryloyloxydodecyl Pyridinium Bromide (c21h34brno2) Coating Intended To Reduce Microbial Contamination On The Surface Of The Device Prior To Implantation. The Device Does Not Contain Antimicrobial Agents That Act Within Or On The Body..

Submission Details

510(k) Number DEN220015 FDA.gov
FDA Decision Not Cleared Not Substantially Equivalent (DENG)
Date Received February 28, 2022
Decision Date April 05, 2024
Days to Decision 767 days
Submission Type Direct
Review Panel Orthopedic (OR)
Summary -

Device Classification

Product Code QZY - Spinal Fusion System With 12-methacryloyloxydodecyl Pyridinium Bromide (c21h34brno2) Coating
Device Class Class II - Special Controls
CFR Regulation 21 CFR 888.3071
Definition A Spinal Fusion System With 12-methacryloyloxydodecyl Pyridinium Bromide (c21h34brno2) Coating Is A Rigid Metallic Implant System Compromised Of Single Or Multiple Components Intended To Provide Immobilization And Stabilization Of Spinal Segments As An Adjunct To Fusion In Skeletally Mature Patients. The Device Includes A 12-methacryloyloxydodecyl Pyridinium Bromide (c21h34brno2) Coating Intended To Reduce Microbial Contamination On The Surface Of The Device Prior To Implantation. The Device Does Not Contain Antimicrobial Agents That Act Within Or On The Body.